News & Announcements Year None20222021202020192018 Jan 10, 2022 Cerevel Therapeutics to Present at 40th Annual JP Morgan Healthcare Conference: Additional Details of Phase 2 Program for Emraclidine (CVL-231) in Schizophrenia to be Presented Jan 03, 2022 Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
Jan 10, 2022 Cerevel Therapeutics to Present at 40th Annual JP Morgan Healthcare Conference: Additional Details of Phase 2 Program for Emraclidine (CVL-231) in Schizophrenia to be Presented
